Focus
September 15, 2006

Johanna Seddon, Mark Daly GENOMICS: Five Gene Variations Hike Risk of Macular Degeneration
About half of the genetic risk for the leading cause of vision loss in older people comes from only five common single-unit variations in the DNA code spread over three genes, says a study in the Aug. 27 online Nature Genetics from Johanna Seddon, Mark Daly, and their collaborators. The findings may encourage people at high risk of advanced age-related macular degeneration (AMD) to quit smoking, lose weight, and eat more vegetables to reduce their chances of disease. In the long run, the greatest value of the work is to expose the underlying disease mechanisms and develop interventions that better prevent or treat AMD.


Charles Czeisler, Christopher Landrigan MEDICAL TRAINING: Most Residents Break Work Limits, Many Pay Price in Self-injury
Medical residents can spend 30 consecutive hours in the hospital, much of that time on their feet working. A study in the Sept. 6 Journal of the American Medical Association suggests that such extended work shifts could be dangerous. Najib Ayas, Charles Czeisler (on right), and colleagues surveyed 2,737 first-year residents and found that one third had accidentally stabbed themselves with a contaminated needle or scalpel while working an extended shift. An obvious solution to the problem is to limit the number of hours doctors work. Yet in a study appearing in the same issue of JAMA, Christopher Landrigan (on left), Czeisler, and colleagues found that interns routinely violate work-hour limits established by the Accreditation Council for Graduate Medical Education.


Joshua Salomon INFECTIOUS DISEASES: Shorter Course Drugs Against TB May Multiply Long-term Benefits
New drugs against tuberculosis that are now in development could shorten the effective treatment regimen. A shorter course could mean greater compliance and lower risk of drug resistance and disease spread. A computer model developed by Joshua Salomon and his colleagues suggests that a two-month course of effective therapy rather than the current six or more months could ultimately save millions of lives. Their findings are reported in the August issue of PLoS Medicine.

Copyright 2006 by the President and Fellows of Harvard College